← Insider buys

Paul Andrew Gendron has bought INFU on 5 days since Mar 2020

Director at InfuSystem Holdings, Inc.

SEC CIK 0001769450 · Filings on SEC.gov ↗

$303KBought
$0Sold
May 12Last buy

Paul Andrew Gendron's record

3 months after each buy, from the first price a copier could get.

+6.5%Average
+5.7 ptsVs S&P 500
1 of 3Higher

3 buys since 2020 with 3 months of prices.

Every filing

5 filings since Mar 2020, newest first

About Paul Andrew Gendron

Paul Andrew Gendron is a Director at InfuSystem Holdings, Inc., a national healthcare service provider specializing in durable medical equipment and outpatient infusion services ( He joined InfuSystem's Board of Directors in May 2019 after serving as a financial consultant to the Company ( As a company insider and board member, Gendron has demonstrated ongoing commitment to InfuSystem through direct equity ownership, holding 70,000 shares of common stock following a significant acquisition in recent years (

Gendron's involvement with InfuSystem reflects his engagement in the healthcare services sector, particularly in the oncology and infusion pump business segments that constitute the Company's core operations ( His background in financial consulting prior to joining the board, combined with his director-level responsibilities overseeing corporate governance and strategic direction, positions him as a key stakeholder in InfuSystem's Patient Services and Device Solutions business segments (

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.